Registration will start at 9am, with the first lecture from 10am.
As usual, abstracts will be presented during the day, and there's an exhibition to visit during breaks and lunch.
Hot ophthalmology topics such as rhytidectomy and facial reconstruction will be discussed, with lectures presented by renowned veterinary and human ophthalmologists.
The day will end with a Q&A session where all lecturers will take part.
Veterinary surgeons need to be a member of BrAVO to come to the event, which costs £120.
There is a reduced price of £90 for vet students and nurses, who don't have to be a member to attend.
For more information, visit https://bravo.org.uk
The event offers over 80 hours of CPD across seven streams – with everything from hypotension and sepsis to breaking bad news to clients – as well as world-renowned speakers and networking opportunities.
Søren Boysen from the University of Calgary in Canada and Sophie Adamantos from Paragon Referrals in Wakefield, are among several high-profile speakers at this year’s Congress.
Chief Executive for GB Snowsport, Victoria Gosling OBE, will open Congress as keynote speaker where she’ll focus on perseverance, resilience and teamwork.
Also speaking are Prof. John Williams, Richard Casey, executive director at the World Small Animal Veterinary Association and VDS trainer Elly Russell.
Arlene Connor, an RVN and head of clinical operations at Vets Now and IVC Evidensia has planned the programme alongside national ECC lead Dan Lewis (pictured right).
She said: “We’re so excited to be returning to the Royal Armouries for our 19th Vets Now ECC Congress – around a theme which celebrates us all being together again.
"The past two years have been a challenge for all of us in the veterinary professions and we hope to mitigate that with a return to face-to-face learning and networking, as well as the chance to have some fun.
"Events like this can be hugely inspirational — for the organisers as well as the attendees — and we truly can’t wait to welcome everyone through the doors like old times.”
Dan added: “There’s a brilliant line-up of live speakers, workshops, a packed exhibition hall and more opportunities than ever for delegates to meet old friends and make new ones, as well as to learn from some of the world’s leading veterinary experts discussing emergency and critical care.
“Our programme again this year has been carefully tailored to provide an inclusive learning experience for vets and vet nurses no matter what stage they’re at in their career, from students through to specialists.
Tickets range in price from £45 + VAT for exhibition-only tickets, up to £470 + VAT for a vet to attend for 2 days plus the Gala dinner.
To book your ticket, go to www.vets-now.com/congress2022
Vetoquinol UK has launched Marbocyl Solo – a one shot treatment for Bovine Respiratory Disease. Marbocyl Solo is a 100mg/ml solution of marbofloxacin given as one injection IM at 8mg/kg. It treats sick animals fast, killing bacteria in one go, therefore minimising lung damage and consequential morbidity. This fast action reduces the risk of the spread of infection. On top of that, Marbocyl Solo has a meat withdrawal of only 3 days (milk 3 days). “Marbocyl is a well proven antibacterial that is extensively used in cattle practice,” explains Alvin Cerely, Marbocyl’s product manager. “Marbocyl Solo is exceptionally well placed for applying ‘concentration killing’ or a‘strike action’ strategy as opposed to a ‘long action’ strategy used by other antibiotics. Marbocyl Solo is available as a separate presentation to Marbocyl 10% to avoid confusion, particularly with farmers, on different dosage regimes and withdrawal periods.”
Marbocyl Solo is available now and details have been mailed to all cattle vets in the UK and Ireland. Please contact your Vetoquinol representative or telephone 0800 169 8197 for more details.
A Pet Obesity Task Force, the first of its kind in the country, has been launched at the European Pet Obesity Conference, hosted by Hill’s Pet Nutrition to help tackle the growing number of obese and overweight pets and put in place strategies to help overcome the condition.
The Task Force hopes to raise awareness of the growing health implications of obese and overweight pets, such as diabetes and osteoarthritis. The fact that pets are obese or overweight is often overlooked by owners and the group also aims to encourage them to identify weight problems and seek appropriate advice from vets.
Mark Evans, chief veterinary adviser at the RSPCA, who will be sitting on the board, comments: “We’ve been trying to treat and prevent pet obesity for 20 years, but the problem hasn’t gone away. In fact it seems to have got worse despite everyone’s efforts. It’s incredibly frustrating. So, is there any point in fighting on in the same old way if we’re not winning the battle?
“Let’s take a step back, review our knowledge, re-evaluate our approaches, think outside the box and innovate. What could we learn from social scientists, human psychologists and others engaged in trying to tackle the very same problem in people – especially children?”
Members of the Pet Obesity Task Force include:
Mark Evans, chief veterinary adviser, RSPCA BVetMed MRCVS Professor John Innes BVSc PhD CertVR DSAS(Orth) MRCVS Professor Danielle Gunn-Moore BSc BVM&S PhD MACVSc MRCVS Daniel Chan DVM DipACVECC DipACVN MRCVS Nicola Ackerman BSc(Hons) RVN Cert SAN MBVNA Rachel Casey BVMS Dip(AS)CABC MRCVS Dr Ian Campbell GP Mike Jessop BVetMed MRCVS Dr Jacques Debraekeleer DVM, DipECVCN Simon Wheeler Head of marketing at Petplan
Following a nationwide search to find the UK's top veterinary professionals for 2010, Petplan has announced the winners of the Veterinary Awards.
The Petplan Veterinary Awards recognise and applaud staff and practices throughout the country that have delivered an exceptional level of care to the nation's pets and their owners.
Alison Andrew, Petplan's Marketing Manager, says she is thrilled by the ongoing success of the awards. "Britain is known to be an animal-loving nation and with millions of households owning cats and dogs, pets play a central part in family life. The Petplan Veterinary Awards give us the opportunity, on behalf of all pet owners across the UK, to thank the veterinary profession for the outstanding service they provide to our pets.
"This is the 11th year of the awards and we received over 1800 nominations, which really highlights the high regard that the profession and pet owners have for these awards."
VET OF THE YEARMike Hewitt, Wendover Heights Veterinary Centre, Buckinghamshire Having worked in the profession for over 20 years Mike is highly respected by clients, valued by colleagues and loved by pets. Having received so many heartfelt customer nominations, Mike's constant professionalism and approachable manner shone through.
VET NURSE OF THE YEARLouise Want, Feldon Veterinary Centre, WarwickshireThe constant support and care Louise provides to both her colleagues and clients really stood out. She is a great inspiration to all and having worked in the veterinary profession for 30 years, Louise is as passionate and dedicated, as when she first started.
VET RECEPTIONIST OF THE YEAR Carol Dawson, Kingsteignton Veterinary Group, Devon Carol's compassionate and professional manner really impressed all the judges. Clients instantly feel at ease because of her caring smile and welcoming attitude, while her colleagues find her a great inspiration.
VET PRACTICE OF THE YEAR Mill House Veterinary Surgery and Hospital, Norfolk Mill House Veterinary Surgery and Hospital provides an incredibly high level of service to their clients, and as a collective are extremely dedicated and welcoming. Taking pride in their work they are known by their clients for being efficient, friendly and helpful.
Bimeda has launched Recocam, a 20mg/ml meloxicam preparation licensed for use as a single injection course in cattle, horses and pigs.
Bimeda's Head of Technical Services, Padraig Hyland MVB said: "Meloxicam's anti-inflammatory credentials and safety profile is well proven and it remains rightly popular with large animal vets. With our manufacturing expertise it makes sense to add this widely used product to our portfolio. Our aim is to provide a comprehensive range of both established standards and new innovative products for cattle and equine vets, and this is just another step in that process."
Bimeda says Recocam has a broad range of indications including acute respiratory infections, in combination with oral re-hydration in diarrhoea therapy and acute mastitis, for non-infectious locomotor disorders and lameness in pigs and alleviation of inflammation and pain in both acute and chronic musculo-skeletal disorders and pain relief associated with equine colic. In cattle Recocam can be given by single subcutaneous or intravenous injection.
The course offers veterinary surgeons and students six hours of CPD covering the five stages of EBVM and an overview of its evolution.
Users can progress through the six modules in order, or dip in and out of individual sections to deepen their knowledge in particular areas. The course includes a number of practical examples and quizzes, and there's a certificate of completion at the end.
The course can also be used as a reference tool for specific aspects of EBVM, such as how to search the literature effectively.
RCVS Knowledge says the new release of EBVM Learning has been well received by veterinary surgeons and nurses who helped test the course. Lucie Goodwin MRCVS said, simply: “This course is excellent.” Chris Gush, Executive Director of RCVS Knowledge (pictured right), said: “This fresh iteration of our EBVM Learning course is the culmination of a huge amount of committed work from an international network of leaders in EBVM, and we are proud to launch it on our new, accessible platform RCVS Knowledge Learn. The course constitutes an important way in which the charity supports all veterinary practitioners to advance the quality of care they provide through evidence-based veterinary medicine, regardless of their role, location or background.”
EBVM Learning can be accessed for free at http://learn.rcvsknowledge.org/ebvm-learning
The series comprises of six half-hour modules presented by leading European Specialists, starting with ‘Feline anorexia in clinical practice’ by Tommaso Furlanello Dr Med Vet, PhD, EBVS European Specialist in Veterinary Clinical Pathology and clinical director at San Marco Veterinary Clinic and Laboratory in Veggiano, Italy.
In the subsequent five sessions, participants will be able to work through a variety of real-life, interactive patient case studies presenting with complex underlying conditions, include sessions on chronic kidney failure (CKD) and cancer.
Completing the first two modules unlocks the remaining four modules needed to gain ‘Purrfect Partner’ accreditation.
The series counts for three hour's CPD.
www.dechra.co.uk/academy
Animalcare has announced that a new indication for chronic renal insufficiency in cats has been approved in the licence for Benazecare 5mg.
Benazecare is a POM-V ACE (angiotensin converting enzyme) inhibitor containing benazepril hydrochloride, which was originally launched in the UK in 2007 for the treatment of congestive heart failure in dogs.
For more information, contact Animalcare at www.animalcare.co.uk
The Government has been forced to scrap plans for compulsory dog insurance less than a two weeks since they were revealed in leaked Defra documents.
Environment Secretary Hilary Benn has now ruled out the idea.
Apparently, the climbdown followed protests that compulsory insurance was no more than a 'dog tax' which would do nothing to curb the problem of dangerous dogs.
There's a certain irony in the way the story was reported in The Sun newspaper, with the headline: 'Labour forced to ditch pet plan'.
Indeed!
Stephen has been an elected member of RCVS Council since 2012, having previously been an appointed member of Council representing the Royal Veterinary College between 2001 and 2009.
In 2016 he was re-elected to Council to serve a further four-year term and currently chairs the Legislation Working Party.
Stephen graduated from Cambridge in 1980 and subsequently spent time as a large animal practitioner. After undertaking further training in equine surgery and diagnostic imaging at the University of Liverpool, he studied for a PhD at the Royal Veterinary College (RVC) before returning to Liverpool as a Lecturer in Equine Orthopaedics.
He went back to the RVC in 1993 to concentrate on equine clinical services and, in 1997, became Head of the Farm Animal and Equine Clinical Department. He was appointed the RVC’s Vice-Principal for Teaching from 2000 to 2013, Deputy Principal from 2013 to 2017 and currently holds the post of Senior Vice-Principal.
Addressing the need for a learning culture in his speech Stephen said: "Veterinary graduates have never had greater knowledge and technical skills than those graduating this year. But this can make their job so much harder when the certainty of scientific knowledge is confronted with the uncertainties of the sick animal, and the increasing number of possibilities for treatment have to be weighted alongside ethical and economic considerations.
"Of his age, but also prophetic of our age, the philosopher Bertrand Russell commented that 'habits of thought cannot change as quickly as techniques with the result that as skill increases, wisdom fails'.
"So it is important that our young professionals are well-prepared in terms of professional, non-technical skills to cope with the sheer variety of challenges that they encounter, and we, as a profession, within our professional model, provide a nurturing learning culture rather than the blame and cover-up culture that the current emphasis on external regulation fosters, so pervasively and distressingly."
Stephen added that his other priorities would be working with the British Veterinary Association and other stakeholders to uphold the College’s first Brexit principle that 'vital veterinary work continues to get done', a project on graduate outcomes, which flows from the Vet Futures project, and the Legislation Working Party.
New statistics from the Voice of the Veterinary Profession Spring 2022 survey showed that while veterinary work is often seen as a vocation, 77% of vets list pay among their top five priorities when choosing a job.
Other deciding factors include geographical location (74%), area of practice (62%), low staff turnover (45%) and structured career progression (28%).
However only 42% of vets who responded to the survey considered their pay and benefits to be either ‘good’, ‘very good’, or ‘excellent’.
BVA President Malcolm Morley, said: “Fair, transparent and equal pay is one of the keystones of good veterinary workplaces.
"Whether you’re an employee, a manager or an employer, it’s vital that everyone feels confident that their workplace approaches pay in a clear and consistent way.
"This isn’t about paying everyone more; it’s about using objective criteria and transparent pay scales to ensure the whole team understands how decisions about reward and recognition are made and what they can do to access higher pay.”
The new resource, created for BVA members as part of its Good Veterinary Workplaces campaign, includes information for veterinary employers on the benefits a clear pay structure can bring for the whole team.
It demonstrates the positive impact transparency around reward and recognition can have on employee fulfilment and retention, and outlines the legal requirements of employers to ensure that pay is equitable.
It also offers tips for employees and managers for approaching conversations about pay and emphasises the importance of considering ‘total reward’ during these conversations.
Total reward is the entire sum of a job’s offering including, but not limited to, salary, commission structure, benefits package, CPD, work/life balance, promotion opportunities, travel expenses, accommodation, and so on.
Malcolm added: “We know that pay can be a fraught, and even somewhat taboo, subject but it is one that we all have a responsibility to tackle if we want to ensure that veterinary professionals are fairly rewarded for their work.
"We hope that this new guide will support all our members and equip them with the knowledge required to ensure they can confidently navigate conversations about pay.”
https://www.bva.co.uk/talking-pay
There are 15 candidates contesting six places in the RCVS Council; 16 if you include the perennial Dr Lonsdale. Three are existing Council members eligible for re-election and the remaining 13 candidates are not currently on Council:
Ballot papers and candidates’ details are due to be posted to all veterinary surgeons eligible to vote during the week commencing 13 March, and all votes must be cast, either online or by post, by 5pm on Friday 28 April 2017.
Once again the College is inviting members of the profession to ‘Quiz the candidates’ by putting their questions directly to all those standing for election. Each candidate will then be invited to choose two questions to answer from all those received, and produce a video recording of their answers. Recordings will be published on the RCVS website on Thursday 16 March.
The biographies and statements for each candidate in the elections can be found at www.rcvs.org.uk/vetvote17.
Eleanor Ferguson, RCVS Registrar, said: "This year we will be publishing the candidate biographies and statements online ahead of the start of the official voting period. This is to allow both veterinary surgeons and veterinary nurses to be better informed about the candidates and their reasons for standing before they put their questions forward.
"We would strongly encourage all members of the professions to review the candidate profiles and pose questions for them to answer. We hope it will spark some interesting debates about how the profession is regulated."
You can email your question (NB only one per person) to vetvote17@rcvs.org.uk, post it on the College’s Facebook page (www.facebook.com/thercvs) or on Twitter using the hashtags #vetvote17, by midday on Monday 27 February.
A DNA test which will save foals from unnecessary pain and suffering, and ultimately death, has been launched by the Animal Health Trust.
Foal Immunodeficiency Syndrome (FIS), a genetic disorder which is known to affect Fell and Dales ponies, causes foals to become anaemic and prone to opportunistic infections. Any foal born with the syndrome will not survive.
The new diagnostic DNA test, which costs £40, is the result of ten years of research by the Animal Health Trust (AHT) and the University of Liverpool. The test will not only identify foals which have the fatal condition but will highlight adult ponies who are carriers of the genetic trait which causes the syndrome. Affected foals will be prevented by avoiding covering a carrier mare with a carrier stallion.
Owners and breeders who wish to find out the genetic status of their ponies can arrange for a simple pulled mane or tail hair sample to be taken by a vet and submitted to the AHT. The Fell Pony or Dales Pony Societies will supply sample bags for submission on request. A fast-track system to identify foals suffering with the condition will report results within three working days.
The team that developed the DNA test was led by the AHT's Dr June Swinburne and Professor Stuart Carter of the University of Liverpool with research student Laura Fox-Clipsham. They believe that by using the test, owners and breeders will eventually be able to eradicate this awful condition.
Dr. June Swinburne, said: "The DNA test gives owners and breeders the power to overcome this devastating illness. It enables them to make informed decisions about which ponies to breed. We have already had samples submitted by HM The Queen from her own breeding stock of Fell ponies. I'd urge any breeders of Fell or Dales ponies to submit samples in order to arm themselves with the facts they need to prevent the birth of affected foals and thereby avoid this distressing condition."
Professor Carter, said: "The research, and ultimately the DNA test, has only been possible thanks to funding from The Horse Trust and the support of the Fell Pony Society and the Dales Pony Society who have supplied DNA samples. We consider that the efforts of all involved in enabling this research have lead to a major advance in animal welfare."
For more information on testing, contact the Fell or Dales Pony Societies. Alternatively visit the AHT website http://www.aht.org.uk/genetics_fis.html or email FIStesting@aht.org.uk
RCVS Council has unanimously elected Mrs Jacqui Molyneux to become its new Junior Vice-President. She will take up office on RCVS Day, 1 July 2011.
Jacqui said: "As I have become more and more involved with the RCVS and the work of its committees I am amazed at the amount of work being done behind the scenes by both Council Members and the RCVS staff. It's sad that many of the profession live in fear of the RCVS as they are only aware of its regulatory function.
"During my time on the Officer team, communication with the profession will be a priority, not for the vocal minority, but with the silent majority who have no idea of the breadth of the work that the RCVS undertakes each year."
Jacqui graduated in 1981 from the University of Bristol and started her career in small animal practice in Liverpool, before moving to the North East, and setting up her own practice. Following its rebuilding, the practice was accredited as a Veterinary Hospital in 2002 and, four years later, has become RCVS Practice Standards Scheme accredited.
Since her election to the RCVS Council in 2005, Jacqui has chaired the Small Animal Certificate Board and served for four years on the Disciplinary Committee. She has also been Vice-Chairman of the Veterinary Nurses Council since 2007.
From 2009, Jacqui has chaired the RCVS Awarding Body Board, including the review of Veterinary Nursing.
Jacqui is currently President of the Society of Practising Veterinary Surgeons (SPVS). She is studying for a Masters in Clinical Oncology with the University of Birmingham, and holds an RCVS Certificate in Small Animal Surgery awarded in 2000.
Zoetis has announced the availability in the UK and Ireland of Poulvac IBQX, the first specific vaccine against the QX strain of the infectious bronchitis virus.
For the past two years the vaccine has only been available with a special import certificate from the Veterinary Medicines Directorate for use on flocks where the QX virus has been isolated.
According to the company, this variant IB strain has been an increasing problem in European countries over the last 10 years and was first seen in the UK in South-East England in 2007. Since then QX has been isolated from a number of commercial layer and broiler flocks, leading to inferior performance and increased mortality.
James Porritt, Zoetis Poultry Manager for the UK and Ireland said: "Poulvac IB QX adds another protection dimension to our extensive IB vaccine portfolio. The Zoetis IB portfolio offers the widest choice and with Poulvac IBMM + ARK we have the UK's only bivalent live vaccine licensed for day-old use providing a Massachusetts strain and protection against 793/B/91 variant type strains lasting for six weeks post vaccination. Other IB Vaccines include Poulvac H120 and the UK's only other bivalent live vaccine Poulvac IB Primer."
Poulvac IB QX vaccine is based on a live attenuated virus and is administered as a coarse spray to broilers from day-old and to layer pullets or broiler breeders from seven days of age. Protection has been demonstrated by challenge study to last for 63 days after vaccination.
Zoetis says the vaccine is often used on the farm, but can be administered to chicks at the hatchery if adequate controls are in place to avoid spread to other chicks that will be moved to non-QX exposed flocks.
Dr Stuart Andrews, Poultry Veterinary Manager for Zoetis said: "In countering the QX virus strain some existing vaccines have been used to provide a degree of cross-protection. However, it is important to appreciate that Poulvac IB QX is a vaccine homologous to any IB QX field strain and so will provide even better protection.
"Furthermore, our in-house PCR and DNA sequencing service allows us to monitor carefully the field situation to ascertain which IB strains are currently causing field outbreaks and enable us to recommend adaptations to particular vaccination programmes.
"The full approval for the Poulvac vaccine will make it easier and more effective to tackle specific QX infections without having to apply for an import certificate."
The College says the increase is needed to fund a number of ambitious projects and make sure the it is fit for the future.
The approved fee rise will apply to the 2020-21 annual renewal fee, which is due to be paid by 31 March 2020.
Increases will also be applied for those registering on or after 1 April 2020, including the restoration fee for those applying to re-join the Register.
Lizzie Lockett, RCVS CEO, said: "While we appreciate that asking people for more money is never going to be popular, I would like to reassure the profession that the fee rise is both a necessary piece of financial future-proofing and will also help fund current projects and future initiatives stemming from our new Strategic Plan.
"Many of our existing projects such as the RCVS Leadership programme, the ViVet innovation project, the Fellowship and the Mind Matters mental health initiative, have an increasing workload, often due to popular demand, which requires additional resources – including staffing – to meet those needs. There is also increasing demand on some of our core regulatory functions such as our concerns investigation and disciplinary processes, including the Veterinary Client Mediation Service (VCMS), and our Education Department which is responsible for ensuring standards in an increasing number of educational institutions both domestically and internationally.
"Furthermore, there is lots of additional work on the horizon, much of which relates to improving and enhancing aspects of the profession and stems from our newly approved Strategic Plan, which will be published soon. For example, RCVS Council has just agreed an ambitious overhaul of the Professional Development Phase to help graduates better transition to life in practice; we are carrying out an increasing amount of work on understanding the barriers to diversity and inclusion in the veterinary profession: and, we are looking to relocate the College in order to be better able to accommodate the increasing number of staff and functions the work we do requires.
"In terms of future-proofing, we also need to make sure we have sufficient financial security for a potential decrease in the number of veterinary surgeons currently registered with us, as well as the number of veterinary surgeons joining the Register on an annual basis, that may arise when the UK fully leaves the EU at the end of the transition period in December 2020."
The current levels of RCVS fees are able to view at: www.rcvs.org.uk/how-we-work/fees/, which will be updated with the new fees shortly.
Vets4Pets says research has shown that 28% of cats between 11 and 15 years show at least one clinical sign of cognitive dysfunction, with this figure increasing to 50 per cent in cats over 15 years of age1.
The prevalence in dogs is also reported to be significant, with some estimates indicating that 28% of 11- to 12-year-old dogs and 68% of 15- to 16-year-old dogs are showing clinical signs of the condition2.
A 2010 study, which used data from pet owner questionnaires, also estimated that the prevalence of cognitive dysfunction was 14.2% in dogs over the age of eight years, yet only 1.9% of older dogs were clinically diagnosed with the condition3.
The survey of 2,000 owners, which was conducted for Vets4Pets by market research company OnePoll, found that half would not be confident identifying the early indicators of cognitive dysfunction, namely: confusion, anxiety, restlessness, and a decreased desire to play.
62% said they would put any significant behavioural changes in their pet down to them getting old, and more than three in five admitted they can find it difficult to understand the signs of when they should be taking their pet to visit the vet.
Up to 33% delay taking their pet to the vet as they worry they might get bad news
However, 35% said they have or will increase the number of routine visits to the vets as their pet gets older.
Dr Huw Stacey, Director of Clinical Services at Vets4Pets said: “It is only natural that many pet owners can have apprehensions about bringing their pet along to the vets, which is just a testament to how much they care.
"But this is also why it’s incredibly important that we as an industry have the expertise and training needed to properly support pet owners with this diagnosis."
“Our ultimate goal is to help educate vets and nurses across the nation and empower them in their decision making when diagnosing elderly pets, as well as helping pet owners to care for their pets so they live a longer, healthier and happier life.”
As part of its campaign, Vets4Pets has sponsored a free CPD webinar in which Dr Sarah Heath, RCVS and European Veterinary Specialist in Behavioural Medicine (pictured right), considers ways in which the veterinary profession can improve the detection of this condition, enabling them to offer practical advice and support for senior pets and their owners.
The recording consists of a 45-minute webinar and a 15-minute Q&A session which will be available for anyone to watch for a year.
To watch the webinar, visit: https://vimeo.com/684610594/3d9d258bcb.
References
Merial has launched a limited trial pack version of Equioxx® (firocoxib), the company's COX-2 specific NSAID for horses, which contains 10 tubes of the oral paste.
According to the company, Equioxx is the only equine NSAID that is highly COX-2 selective, acting to reduce pain and inflammation whilst preserving the natural physiological effects of the COX-1 enzyme, at therapeutic levels.
The company also claims that field studies have confirmed that firocoxib is highly effective at controlling pain and improving function in horses with chronic osteoarthritis.
Jim Tipp BVSc MRCVS, partner at Shropshire based Fyrnwy Equine Clinics said: "As a COX-2 specific NSAID it is not only a good analgesic, but is also an excellent anti-inflammatory. In addition, the COX-1 sparing properties of Equioxx are beneficial where there is increased risk of ulceration."
Equioxx is also available as a low dose injectable solution. For more information contact Merial Customer Services on 0870 6000 123.
The webinars are being presented by Sian Tranter MRCVS, who has a business called VetReflect which supports veterinary staff in resolving issues in their day-to-day working life, clinical or non-clinical, with support, guidance and direction.
In the hour-long interactive webinars, Sian will concentrate on providing practical advice to support clinicians and promote both personal and team development.
The first webinar, "Using Clinical Supervision – Looking After Ourselves", will focus on how professionals can improve their job satisfaction and reduce the impact that work has on the rest of their lives.
The session, which will take place on Thursday 31st March at 3.00pm, will include the opportunity to complete a personal audit to identify the actions required to achieve these goals.
To register for the event visit: https://tinyl.io/5aIa
The second webinar, taking place on Thursday 28th April at 7:30pm, is titled: "Using Clinical Supervision – Looking After Our Team", and will focus on applying practical and relevant tools to get the best out of veterinary teams to promote teamwork, performance and positivity.
To register for the event, visit: https://tinyl.io/5aIf
The webinars are free-of-charge and are available to veterinary clinics across the UK and the US, including those not affiliated to the Premier Vet Alliance.
A research project funded by The Horse Trust has discovered that a racehorse's performance does not markedly change after it has recovered from a tendon injury.
The research was led by Bryan O'Meara, who is in the final year of a three year clinical training scholarship funded by The Horse Trust.
Mr. O'Meara carried out the research at Donnington Grove Veterinary Surgery in Newbury, under the supervision of epidemiologist Dr Tim Parkin from University of Glasgow.
Tendonitis is one of the most common musculoskeletal injuries in racehorses, with a prevalence of 11-30%, according to earlier research.
Mr. O'Meara examined the clinical records and racing histories of 400 racehorses who had been treated for superficial digital flexor (SDF) tendonitis injuries over a five year period (2003-2008).
The race records of horses affected by tendon injury were compared with 400 matched control horses that had never suffered SDF tendon injuries.
The controls were horses training in the same establishment at the time of injury and of the same age and sex as the case horse.
The research looked at the performance of the racehorses in races before and after treatment for the injury, and at the performance of the control horses before and after the treatment date. The Racing Post Rating (RPR), which is published by the Racing Post after every race, was used as a measure of performance.
Mr. O'Meara found that there was no significant difference in RPR before and after the treatment date in case and control horses.
According to The Horse Trust, this result is unexpected as in vitro studies have found that healed tendon tissue has reduced elasticity due to the presence of scar tissue. This suggests that a horse with a healed SDF tendon would need to work its muscles harder to compensate and would therefore be expected to have lower performance.
Mr. O'Meara said more research is needed to back-up his finding that performance isn't significantly affected by tendon injury: "It could be that using Racing Post Rating to measure performance isn't sensitive enough to pick up a change in the horse's performance. However, it's encouraging that there's no marked change in performance after a horse has recovered from a tendon injury. These findings show that there's no need to give up on a horse that has a tendon injury - they can still come back and perform well, or can be used for other, less demanding riding activities."
The research also found that there was no significant difference between case and control horses when returning to racing and completing three races. Only after completing five races, or three years post treatment, was a significant difference found between case and control horses. This finding is a step towards developing a more accurate assessment of tendon treatment. Outcome after five races or three years post treatment is a better indicator of the outcome of treatment.
Mr. O'Meara said: "At the moment, some tendon treatments state their success as the percentage of horses that return to racing after treatment. However, we've shown that there's no significant difference between case and control horses at this time. At the moment, there are a myriad of treatments available to treat tendonitis. Hopefully this finding will be used in further research to learn which treatments are most effective."
Mr O'Meara's research also found a link between SDF tendon injury and the racehorse competing at its maximum performance level: the case horses were significantly nearer to their pre-injury maximum performance level in the race immediately before injury (compared to matched controls), suggesting that they were competing nearer their individual maximum performance level when the SDF tendon injury occured.
Dechra Veterinary Products Brand Manager Craig Sankey said: "Hyperthyroidism is a common endocrine disorder that affects thyroid production in older cats. It’s a lifelong condition that requires careful understanding and management by both vets and owners.
"The video presentation aims to illustrate how, with flexibility and precision, you can take control of hyperthyroidism and restore the natural poise of your hyperthyroid patients."
To watch the film and enter the competition, visit: www.dechra.co.uk/3greatreasons.
Competition closes February 28th 2017.
Novartis Animal Health Inc. has completed an agreement with Luitpold Pharmaceuticals, Inc. that grants marketing rights for Adequan® Equine to Novartis in all major equine markets outside the U.S. The first launch of Adequan® Equine by Novartis will take place in Canada in June.
Adequan® Equine is indicated for treating joint dysfunction and lameness in horses caused by injury or degenerative problems. It is available for intramuscular and intra-articular administration. Adequan® is also indicated for treating joint dysfunction and lameness caused by injury or degenerative problems in dogs.
Mickey McDermott from Novartis' Communications Dept told VetSurgeon that the timing of Adequan's arrival in the UK depends on how long it takes to complete the registration transfers, but that the company hopes it'll be before the end of the year.
The Disciplinary Committee of the Royal College of Veterinary Surgeons has suspended a veterinary surgeon from the Register for nine months for convictions regarding docking puppies' tails and driving offences, and for failing to obtain a client's consent to treatment or explore other treatment options.
At the conclusion of the four-day hearing, Dr Adetunji Ayinla Jolaosho, formerly principal veterinary surgeon at City Vet Clinic in Syston, near Leicester, was found unfit to practise following two convictions for tail docking plus 17 driving and related offences, which also brought the profession into disrepute.
They further found that he failed to obtain consent to remove tissue from Jemma, a Staffordshire Bull Terrier owned by Mrs Hill, and to discuss a reasonable range of treatment options with her, and that this also amounted to serious professional misconduct.
In December 2008, Mrs Hill brought Jemma to Dr Jolaosho to have a lump on her flank drained. Mrs Hill said she made it clear that she had limited finances and nothing other than this treatment should be done without her consent. Dr Jolaosho undertook a biopsy and removed tissue. He told the Committee that he asked his practice manager to contact Mrs Hill and obtain her consent, however, this was not consistent either with the clinical records or a letter sent to Mrs Hill in December 2008.
Caroline Freedman, Chairman of the Disciplinary Committee said: "The Committee is satisfied that Dr Jolaosho did not seek to obtain consent from Mrs Hill before he decided to carry out exploratory surgery. It does not consider that there was any attempt to explore treatment options with Mrs Hill before the surgery other than draining the mass."
On 16 June 2009, Dr Jolaosho pleaded guilty at Market Harborough Magistrates Court to two offences of docking the tails of Rottweiler and Doberman puppies. He was fined £10,000 and ordered to pay court costs of over £3,000. During 2003 to 2008, he was also convicted of 15 driving and related offences and twice of obstructing a police officer.
At the outset of the hearing, Dr Jolaosho admitted his criminal convictions, telling the Committee of his difficulties following the death of his wife in October 2002 and subsequent sole responsibility for his three teenage children. He also said that the tail docking resulted as an oversight on his part and that as the puppies were docked within five days of birth, there were no welfare issues. He emphasised that he had not carried out tail docking since being visited by the RSPCA in July 2008. He also drew to the Committee's attention the fact that, until 2003, he had been of good character.
The Committee accepted that for at least part of the period in question he was suffering from emotional problems following his wife's death, and his continuing financial responsibility for two of his children.
It was however, concerned, that having received a custodial sentence for driving whilst disqualified, he committed further driving offences on release. Nor did they accept that the tail docking was an oversight: in 2006 the RCVS advised Dr Jolaosho to comply with the RCVS Guide to Professional Conduct and not dock dog's tails unless for "truly therapeutic or prophylactic reasons." In view of the seriousness of the charges admitted and proved, the Committee concluded that a period of nine months suspension from the Register would be a proportionate penalty.
Mrs Freedman said: "The primary purpose of the sanctions is not to punish but to protect the welfare of animals, maintain public confidence in the profession, and declare and uphold proper standards of conduct."
She added: "Bearing in mind the financial consequences of the suspension of Mr Jolaosho, the Committee does not consider that any useful purpose would be served by imposing a longer period of suspension. However, Mr Jolaosho should be aware that any further convictions or failure to observe the College's Guidelines are likely to lead to the removal of his name from the Register."
The RCVS Inspiration Award is for a veterinary surgeon or veterinary nurse who has demonstrated the ability to inspire and enthuse others consistently throughout his or her career.
The award is open to those who have inspired and motivated individuals or groups or who have worked at a profession-wide level. It will recognise those who have gone 'above and beyond' what may normally be expected from a professional colleague or tutor.
The RCVS Impact Award is for a veterinary surgeon or veterinary nurse who has made a considerable impact that has affected the profession, animal health or welfare, or public health. Such impact could have been made through any field of veterinary endeavour, including clinical practice, research, education or veterinary politics.
Chris Tufnell, Senior Vice-President of the RCVS, said: "I am very excited to be introducing these two new awards for those veterinary surgeons and nurses who go above-and-beyond the call of duty for the benefit of their profession, animals and society as a whole.
"I am keen to emphasise that these two new awards are relevant for veterinary professionals from all walks of life and any stage of their career – these are not life-time achievement awards but are for those making a tangible difference whether that’s in their practice, their region or across the country as a whole.
"If you know someone like this then I would strongly encourage you to find out more on our website and fill out a nomination form."
These two awards join four others made by the College:
Nominations for all six honours are now open. Nomination forms and guidance notes can be downloaded from www.rcvs.org.uk/honours and any questions can be directed to Peris Dean, Executive Secretary, on p.dean@rcvs.org.uk.
The deadline for making nominations is Friday 22 September 2017.